FUNCTIONAL ANALYSIS OF NF2 GENE MUTATIONS
FUNCTIONAL ANALYSIS OF NF2 GENE MUTATIONS
批准号:
6193800
负责人:
David H Gutmann
金额:
$33.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-28 至 2004-06-30
关键词:
RNA splicing Schwann cells athymic mouse biological signal transduction cell growth regulation cell line cell motility confocal scanning microscopy flow cytometry gene expression gene mutation intermolecular interaction neoplastic process neoplastic transformation neurofibromatosis neurogenetics polymerase chain reaction protein isoforms protein structure function transfection tumor suppressor proteins western blottings
中文摘要
描述(摘自申请者的摘要):对
神经系统肿瘤的分子发病机制,如脑膜瘤和
神经鞘瘤。患有神经纤维瘤病2(NF2)的人会患上这些
肿瘤的发生频率在增加。此外,NF2基因的突变和丢失
表达与散发性神经鞘瘤的发生和发展有关
脑膜瘤,提示NF2基因产物,Merlin是生长的关键
雪旺细胞和脑膜细胞的调节剂。NF2抑癌基因
与连接肌动蛋白的蛋白质4.1的序列相似
从细胞骨架到细胞表面糖蛋白。我们实验室以前的工作
已经证明,Merlin还调节细胞的运动和增殖
随着细胞的扩散。在此应用程序中,我们建议测试以下假设
Merlin集成了几个不同的细胞过程,这些过程对
细胞调节能力反映肿瘤的形成和发展
扩散(肿瘤起始)、细胞增殖(肿瘤生长)和细胞
运动性(肿瘤扩散)。本申请中提出的实验旨在
在确定Merlin肿瘤抑制因子作为负生长因子的作用时
通过定义Merlin功能结构域、关键Merlin蛋白来调节
相互作用和相关的细胞内信号通路。我们有能力
设计合理的神经鞘瘤和脑膜瘤治疗依赖于
更好地理解了Merlin表达缺失和
功能促进肿瘤的形成。
英文摘要
DESCRIPTION (From the applicant's abstract): Little is known about the
molecular pathogenesis of nervous system tumors such as meningiomas and
schwannomas. Individuals affected with neurofibromatosis 2 (NF2) develop these
tumors at increased frequency. In addition, mutations and loss of NF2 gene
expression are associated with the development of sporadic schwannomas and
meningiomas, suggesting that the NF2 gene product, merlin is a critical growth
regulator for Schwann cells and meningeal cells. The NF2 tumor suppressor gene
bears sequence similarity to Protein4.1 proteins that link the actin
cytoskeleton to cell surface glycoproteins. Previous work from out laboratory
has demonstrated that merlin regulates cell motility and proliferation as well
as cell spreading. In this application we propose to test the hypothesis that
merlin integrates several different several cellular processes important for
tumor formation and progression reflected by its ability to regulate cell
spreading (tumor initiation), cell proliferation (tumor growth) and cell
motility (tumor spread). The experiments proposed in this application are aimed
at determining how the merlin tumor suppressor functions as a negative growth
regulator by defining merlin functional domains, critical merlin protein
interactions and relevant intracellular signaling pathways. Our ability to
design rational therapies for schwannomas and meningiomas is dependent on an
improved understanding of the mechanisms by which loss of merlin expression and
function promotes tumor formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuronal Regulation of Low-Grade Gliomagenesis
-
批准号:10412883
-
项目类别:
-
资助金额:$65.72万
-
财政年份:2022
-
负责人:David H Gutmann
-
依托单位:
Neuronal Regulation of Low-Grade Gliomagenesis
-
批准号:10596172
-
项目类别:
-
资助金额:$62.57万
-
财政年份:2022
-
负责人:David H Gutmann
-
依托单位:
T Cell Regulation of Low-Grade Glioma
-
批准号:10700099
-
项目类别:
-
资助金额:$48.33万
-
财政年份:2022
-
负责人:David H Gutmann
-
依托单位:
Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity
-
批准号:10533079
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity
-
批准号:10534120
-
项目类别:
-
资助金额:$76.25万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity
-
批准号:10062526
-
项目类别:
-
资助金额:$68.63万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
-
批准号:9171983
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
-
批准号:9333268
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity
-
批准号:10302300
-
项目类别:
-
资助金额:$68.63万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
-
批准号:9751813
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:David H Gutmann
-
依托单位:
Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management
-
批准号:9297258
-
项目类别:
-
资助金额:$55.15万
-
财政年份:2015
-
负责人:David H Gutmann
-
依托单位:
NEUROFIBROMIN REGULATION OF NEURAL STEM CELL FUNCTION IN VITRO AND IN VIVO
-
批准号:8634142
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
NEUROFIBROMIN REGULATION OF NEURAL STEM CELL FUNCTION IN VITRO AND IN VIVO
-
批准号:8424310
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
NEUROFIBROMIN REGULATION OF NEURAL STEM CELL FUNCTION IN VITRO AND IN VIVO
-
批准号:7800064
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
NEUROFIBROMIN REGULATION OF NEURAL STEM CELL FUNCTION IN VITRO AND IN VIVO
-
批准号:8069186
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
Integrative Approaches to Stroma-Directed Glioma Therapy
-
批准号:8044996
-
项目类别:
-
资助金额:$330.0万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
NEUROFIBROMIN REGULATION OF NEURAL STEM CELL FUNCTION IN VITRO AND IN VIVO
-
批准号:8231378
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2010
-
负责人:David H Gutmann
-
依托单位:
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
-
批准号:8330313
-
项目类别:
-
资助金额:$75.48万
-
财政年份:2009
-
负责人:David H Gutmann
-
依托单位:
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
-
批准号:8245234
-
项目类别:
-
资助金额:$8.26万
-
财政年份:2009
-
负责人:David H Gutmann
-
依托单位:
STROMAL CONTRIBUTIONS TO NF1 GLIOMA FORMATION AND GROWTH
-
批准号:8056647
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2009
-
负责人:David H Gutmann
-
依托单位:
海外基金